Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Amino acid-based formula feeding is associated with increased risk of Clostridioides difficile-associated disease in children younger than two years.

Created on 20 Aug 2026

Authors

Liqian Wang, Jianhua Luo, Jinzhu Geng, Xuyang Zheng, Yangyushuang Xu, Chunning Qiu, Yao Zhou, Xianjun Wang, Yu Chen, Liang Tao

Published in

Gut microbes. Volume 18. Issue 1. Pages 2719259. Dec 31, 2026. Epub Aug 20, 2026.

Abstract

Infants and toddlers were previously considered to be exempt from Clostridioides difficile-associated disease (CDAD). However, recent studies reported that Clostridioides difficile (C. difficile) infection can cause severe gastrointestinal symptoms within this age group, yet the influential risk factors related to CDAD in infants remain unknown. Here, we investigated 27 CDAD cases in infants and toddlers under two and found that the amino acid-based formula (AAF) feeding is a notable risk factor closely associated with the development of CDAD in infants. Infants fed with AAF exhibit reduced levels of Bifidobacteria, which were reported to compete with C. difficile, in their fecal microbiomes. Lastly, we found that mice transplanted with feces from AAF-fed infant donors, compared with those from normal formula (NF)-fed donors, were more susceptible to CDAD. These findings shed light on the understanding of variables influencing infant CDAD and offer valuable insights for its prevention.

PMID:
42622547
Bibliographic data and abstract were imported from PubMed on 20 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement